Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2025)
Top biotech stocks in 2025 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.

Industry: Biotechnology

Overview Zen Rating Price Value Growth Financials

Momentum Sentiment Forecast Dividends Due Diligence

Biotech is Zen Rated F and is the 134th ranked industry out of 145 stock market industries

Ticker	Company	Market Cap	ROE	ROA	ROCE	ROIC	D/E	Current Ratio	Gross Margin	Profit Margin	Operating Margin
TLX	TELIX PHARMACEUTICALS LTD	$2.61B	13.90%	5.20%	7.84%	27.90%	1.67	2.78	65.10%	6.40%	11.87%
CELZ	CREATIVE MEDICAL TECHNOLOGY HOLDINGS INC	$5.44M	-88.90%	-85.20%	-106.61%	3,830.80%	0.05	20.71	60.00%	-99,356.80%	-99,356.80%
HUMA	HUMACYTE INC	$207.87M	N/A	-27.90%	-39.90%	-24.80%	-20.26	1.62	60.50%	-2,353.20%	-1,674.35%
NVAX	NOVAVAX INC	$1.08B	-167.00%	25.50%	50.00%	71.10%	-8.53	2.27	91.80%	32.10%	35.22%
QCLS	Q/C TECHNOLOGIES INC	$20.33M	-121.40%	-48.90%	-25.40%	-419.50%	1.11	1.71	N/A	N/A	N/A
OABI	OMNIAB INC	$300.87M	-23.10%	-20.60%	-22.59%	-84.50%	0.12	5.00	98.60%	-301.80%	-317.49%
ABVX	ABIVAX SA	$8.38B	N/A	N/A	N/A	N/A	0.28	7.86	N/A	N/A	N/A
ARCT	ARCTURUS THERAPEUTICS HOLDINGS INC	$185.53M	-28.70%	-21.10%	-32.68%	-220.10%	0.26	7.86	100.00%	-68.30%	-83.92%
CLRB	CELLECTAR BIOSCIENCES INC	$11.36M	-205.90%	-108.00%	-193.36%	491.60%	0.66	2.77	N/A	N/A	N/A
ANNX	ANNEXON INC	$618.50M	-93.10%	-72.90%	-111.57%	-120.40%	0.42	4.43	N/A	N/A	N/A
ORIC	ORIC PHARMACEUTICALS INC	$783.01M	-45.30%	-41.80%	-32.91%	-55.20%	0.06	14.65	N/A	N/A	N/A
HURA	TUHURA BIOSCIENCES INC	$41.98M	-221.90%	-141.90%	-178.58%	-2,355.40%	0.53	0.40	N/A	N/A	N/A
TARA	PROTARA THERAPEUTICS INC	$203.35M	-35.10%	-32.50%	-39.27%	-63.70%	0.09	13.69	N/A	N/A	N/A
OCUL	OCULAR THERAPEUTIX INC	$2.68B	-87.20%	-57.90%	-65.70%	-252.50%	0.59	7.85	88.90%	-447.60%	-425.87%
XFOR	X4 PHARMACEUTICALS INC	$314.77M	-343.70%	-69.80%	-61.27%	-78.30%	1.65	5.65	83.20%	-279.90%	-252.51%
CRNX	CRINETICS PHARMACEUTICALS INC	$4.56B	-35.10%	-32.00%	-37.71%	-36.00%	0.12	15.12	100.00%	-27,563.30%	-27,563.32%
RVPH	REVIVA PHARMACEUTICALS HOLDINGS INC	$68.92M	-20,541.50%	-187.50%	-494.36%	222.10%	2.15	1.39	N/A	N/A	N/A
NRSN	NEUROSENSE THERAPEUTICS LTD	$19.93M	N/A	-491.20%	1,710.60%	441.30%	-4.25	0.71	N/A	N/A	N/A
MRNA	MODERNA INC	$13.20B	-31.40%	-24.40%	-30.16%	-30.90%	0.30	3.93	48.30%	-139.60%	-141.26%
ANVS	ANNOVIS BIO INC	$96.74M	-153.50%	-125.50%	-184.94%	-8,454.30%	0.31	4.60	N/A	N/A	N/A
NGNE	NEUROGENE INC	$318.32M	-29.80%	-27.50%	-31.17%	-38.50%	0.08	18.39	N/A	N/A	N/A
IMMP	IMMUTEP LTD	$384.08M	-36.90%	-34.30%	-42.57%	-130.80%	0.09	11.69	100.00%	-594.60%	-594.28%
QURE	UNIQURE NV	$1.49B	-373.70%	-35.70%	-20.62%	-22.70%	2.88	7.12	88.10%	-1,492.90%	-1,031.34%
CAPR	CAPRICOR THERAPEUTICS INC	$1.27B	-71.00%	-56.10%	-83.42%	-78.10%	0.51	3.59	100.00%	-736.60%	-736.62%
RNXT	RENOVORX INC	$34.08M	-122.20%	-90.70%	-123.25%	3,053.60%	0.39	5.83	67.80%	-1,196.70%	-1,238.04%
CADL	CANDEL THERAPEUTICS INC	$305.78M	-29.20%	-22.60%	-26.21%	353.60%	0.17	8.25	N/A	N/A	N/A
GANX	GAIN THERAPEUTICS INC	$103.78M	-341.30%	-174.10%	-266.08%	1,085.50%	0.86	2.52	N/A	N/A	N/A
VYNE	VYNE THERAPEUTICS INC	$19.36M	-80.60%	-66.00%	-104.91%	-173.00%	0.13	8.87	100.00%	-6,425.20%	-6,424.43%
LEXX	LEXARIA BIOSCIENCE CORP	$12.96M	-187.00%	-162.00%	-443.82%	-2,392.90%	0.53	2.32	99.60%	-1,686.00%	-1,686.00%
BEAM	BEAM THERAPEUTICS INC	$2.70B	-42.90%	-31.50%	-36.74%	-43.30%	0.36	6.02	100.00%	-744.40%	-744.41%
AVXL	ANAVEX LIFE SCIENCES CORP	$327.91M	-46.80%	-41.50%	-48.89%	423.70%	0.09	11.61	N/A	N/A	N/A
TENX	TENAX THERAPEUTICS INC	$81.79M	-43.20%	-41.50%	-45.03%	1,681.90%	0.07	15.58	N/A	N/A	N/A
NNVC	NANOVIRICIDES INC	$22.32M	-95.80%	-83.80%	-113.25%	-138.60%	0.17	1.06	N/A	N/A	N/A
MRKR	MARKER THERAPEUTICS INC	$21.34M	-92.40%	-75.70%	-77.48%	3,325.10%	0.18	6.50	100.00%	-304.50%	-303.47%
NERV	MINERVA NEUROSCIENCES INC	$28.25M	N/A	-43.70%	-55.18%	-24.10%	-1.81	4.87	N/A	N/A	N/A
IPSC	CENTURY THERAPEUTICS INC	$78.58M	-13.40%	-8.80%	-11.09%	-11.90%	0.39	6.25	100.00%	-23.40%	-21.79%
AMLX	AMYLYX PHARMACEUTICALS INC	$1.32B	-68.90%	-61.50%	-44.49%	-128.50%	0.09	13.70	100.00%	22,448.40%	22,543.91%
AURA	AURA BIOSCIENCES INC	$372.13M	-69.70%	-58.20%	-62.12%	-82.20%	0.21	9.04	N/A	N/A	N/A
AIXC	AIXCRYPTO HOLDINGS INC	$14.14M	-90.50%	-65.20%	-19.08%	-420.70%	0.13	8.83	N/A	N/A	N/A
ZURA	ZURA BIO LTD	$277.65M	-48.20%	-38.30%	-54.26%	359.10%	0.24	5.58	N/A	N/A	N/A
ENVB	ENVERIC BIOSCIENCES INC	$3.03M	-403.40%	-279.50%	-281.40%	1,913.00%	0.26	4.60	N/A	N/A	N/A
SRZN	SURROZEN INC	$186.51M	-5,313.30%	-116.50%	-119.80%	-835.10%	-5.00	13.15	100.00%	-6,400.70%	-6,400.73%
GHRS	GH RESEARCH PLC	$803.90M	-15.80%	-15.30%	-14.53%	-71.20%	0.04	28.32	N/A	N/A	N/A
RYTM	RHYTHM PHARMACEUTICALS INC	$7.48B	-445.30%	-47.70%	-42.34%	-84.70%	1.42	4.75	89.40%	-113.40%	-97.79%
NKTR	NEKTAR THERAPEUTICS	$952.80M	-356.80%	-45.20%	-40.25%	-37.00%	2.54	4.24	87.30%	-192.90%	-151.11%
OVID	OVID THERAPEUTICS INC	$104.68M	-63.70%	-46.10%	-63.68%	-62.50%	0.43	4.24	100.00%	-549.60%	-549.62%
RVMD	REVOLUTION MEDICINES INC	$15.23B	-49.20%	-40.00%	-47.32%	-46.80%	0.41	8.05	N/A	N/A	N/A
OKUR	ONKURE THERAPEUTICS INC	$40.78M	-95.80%	-86.90%	-121.50%	1,899.00%	0.10	11.45	N/A	N/A	N/A
RNAC	CARTESIAN THERAPEUTICS INC	$187.75M	N/A	-12.60%	-13.29%	-27.00%	-11.40	10.67	100.00%	-4,638.60%	-4,371.40%
CRSP	CRISPR THERAPEUTICS AG	$5.32B	-26.40%	-22.50%	-22.79%	-24.00%	0.17	16.22	100.00%	-1,273.70%	-1,263.99%
ACLX	ARCELLX INC	$3.70B	-51.10%	-33.10%	-46.45%	-49.00%	0.49	3.99	100.00%	-607.00%	-695.50%
PRAX	PRAXIS PRECISION MEDICINES INC	$6.82B	-66.90%	-60.30%	-79.49%	-115.20%	0.15	5.18	100.00%	-3,658.50%	-3,658.53%
ADTX	ADITXT INC	$651.75k	-757.20%	-156.60%	472.06%	-351.20%	-2.67	0.02	-1,111.20%	-710,498.70%	-703,444.47%
CMND	CLEARMIND MEDICINE INC	$368.49k	-173.80%	-70.50%	-364.89%	138.60%	2.73	1.32	N/A	N/A	N/A
CTMX	CYTOMX THERAPEUTICS INC	$677.74M	44.50%	20.30%	24.11%	60.40%	0.47	3.64	100.00%	24.70%	24.87%
VTGN	VISTAGEN THERAPEUTICS INC	$30.81M	-90.70%	-76.20%	-92.50%	-747.70%	0.22	5.79	100.00%	-8,631.90%	-8,631.90%
CVKD	CADRENAL THERAPEUTICS INC	$14.76M	-279.50%	-204.50%	-525.99%	928.40%	0.50	3.02	N/A	N/A	N/A
ATON	ALPHATON CAPITAL CORP	$1.19M	-347.70%	-135.50%	-602.49%	2,165.50%	-24.81	2.02	N/A	N/A	N/A
SRPT	SAREPTA THERAPEUTICS INC	$2.20B	-20.30%	-7.40%	-9.81%	-7.10%	1.65	2.95	76.30%	-11.20%	-10.45%
PHVS	PHARVARIS NV	$1.66B	-66.20%	-60.20%	N/A	-1,563.70%	0.09	N/A	N/A	N/A	N/A
IFRX	INFLARX NV	$75.20M	-68.50%	-53.20%	-86.90%	-104.20%	0.44	3.33	-8,223.10%	-63,818.90%	-63,757.59%
MRVI	MARAVAI LIFESCIENCES HOLDINGS INC	$877.07M	-42.60%	-13.10%	-11.90%	-16.40%	1.70	5.29	20.90%	-63.10%	-48.76%
CBIO	CRESCENT BIOPHARMA INC	$164.63M	-84.60%	-71.60%	-46.53%	693.40%	0.19	6.63	N/A	N/A	N/A
CHRS	COHERUS ONCOLOGY INC	$164.38M	-574.70%	34.90%	115.84%	139.50%	4.89	1.24	47.80%	185.40%	199.92%
CLNN	CLENE INC	$69.03M	N/A	-125.60%	-200.24%	-105.20%	-2.81	1.53	82.20%	-14,250.50%	-13,104.67%
ORKA	ORUKA THERAPEUTICS INC	$1.54B	-25.80%	-24.80%	-20.81%	-31.60%	0.05	16.94	N/A	N/A	N/A
VSTM	VERASTEM INC	$518.18M	N/A	-159.10%	-204.07%	-526.30%	-12.39	2.58	82.00%	-1,802.10%	-1,786.77%
INO	INOVIO PHARMACEUTICALS INC	$122.14M	-307.60%	-127.90%	24,665.13%	-846.50%	-9.99	0.79	100.00%	-59,281.70%	-59,281.69%
APGE	APOGEE THERAPEUTICS INC	$5.37B	-39.10%	-36.90%	-42.80%	-46.30%	0.07	15.86	N/A	N/A	N/A
AVTX	AVALO THERAPEUTICS INC	$337.29M	-88.40%	-73.90%	-86.18%	-288.20%	0.37	14.28	54.70%	-52,019.80%	-52,575.52%
CRDF	CARDIFF ONCOLOGY INC	$173.12M	-77.20%	-62.80%	-102.75%	-117.30%	0.31	4.20	100.00%	-10,069.10%	-10,064.27%
TRDA	ENTRADA THERAPEUTICS INC	$419.65M	-26.40%	-22.10%	-26.87%	-25.40%	0.21	14.08	100.00%	-168.20%	-169.85%
IMRX	IMMUNEERING CORP	$364.82M	-73.50%	-65.00%	-26.99%	-1,472.40%	0.06	24.00	N/A	N/A	N/A
NMRA	NEUMORA THERAPEUTICS INC	$292.41M	-113.80%	-96.90%	-154.89%	-242.80%	0.35	6.85	N/A	N/A	N/A
DMAC	DIAMEDICA THERAPEUTICS INC	$441.62M	-83.30%	-73.60%	-61.70%	-90.10%	0.11	10.67	N/A	N/A	N/A
NCEL	NEWCELX LTD	$1.08M	N/A	-337.50%	N/A	363.90%	0.51	N/A	N/A	N/A	N/A
CLYM	CLIMB BIO INC	$291.83M	-26.40%	-25.60%	-28.62%	-33.40%	0.03	18.38	N/A	N/A	N/A
BCAB	BIOATLA INC	$44.27M	N/A	-193.50%	3,116.91%	1,007.10%	-1.51	0.54	N/A	N/A	N/A
ALEC	ALECTOR INC	$152.81M	-123.00%	-27.50%	-42.18%	-38.10%	4.81	3.76	100.00%	-156.00%	-155.96%
IMNN	IMUNON INC	$11.51M	-501.10%	-166.80%	-299.16%	239,282.00%	1.20	1.73	N/A	N/A	N/A
ELAB	PMGC HOLDINGS INC	$1.68M	-82.90%	-63.50%	-70.06%	-523.90%	0.76	1.79	82.20%	458.40%	454.25%
BTAI	BIOXCEL THERAPEUTICS INC	$37.83M	N/A	-185.00%	-738.28%	-61.10%	-1.50	1.18	-28.20%	-9,070.60%	-6,860.51%
ABEO	ABEONA THERAPEUTICS INC	$276.92M	78.40%	48.00%	41.45%	86.10%	0.35	9.74	-22.00%	20,587.50%	21,650.75%
DNLI	DENALI THERAPEUTICS INC	$2.47B	-46.30%	-41.00%	-51.65%	-47.40%	0.14	9.79	N/A	N/A	N/A
RZLT	REZOLUTE INC	$164.13M	-62.80%	-57.10%	-51.99%	-81.70%	0.08	15.15	N/A	N/A	N/A
DNTH	DIANTHUS THERAPEUTICS INC	$1.82B	-33.00%	-31.10%	-22.82%	-34.90%	0.06	17.35	100.00%	-4,104.80%	-4,104.78%
PRQR	PROQR THERAPEUTICS NV	$238.04M	-58.40%	-29.30%	-44.87%	-9,969.30%	1.18	3.36	100.00%	-264.80%	-254.60%
OSRH	OSR HOLDINGS INC	$16.71M	N/A	N/A	N/A	N/A	0.53	0.21	N/A	N/A	N/A
AVIR	ATEA PHARMACEUTICALS INC	$245.32M	-38.40%	-35.90%	-45.29%	-48.10%	0.09	16.66	N/A	N/A	N/A
VANI	VIVANI MEDICAL INC	$101.40M	-293.60%	-79.50%	-142.87%	-80.80%	18.13	0.61	N/A	N/A	N/A
PHIO	PHIO PHARMACEUTICALS CORP	$11.52M	-86.40%	-75.80%	-80.83%	960.20%	0.17	6.90	N/A	N/A	N/A
SGMT	SAGIMET BIOSCIENCES INC	$204.24M	-42.40%	-40.30%	-48.36%	-70.10%	0.08	13.06	N/A	N/A	N/A
GUTS	FRACTYL HEALTH INC	$301.50M	-3,645.20%	-133.00%	-127.83%	-149.70%	-36.96	4.27	100.00%	-4,073,233.30%	-4,073,233.33%
ELDN	ELEDON PHARMACEUTICALS INC	$98.29M	-94.90%	-49.30%	-65.03%	-56.80%	1.10	6.74	N/A	N/A	N/A
VIR	VIR BIOTECHNOLOGY INC	$801.36M	-50.80%	-40.60%	-52.89%	-55.50%	0.28	7.25	95.90%	-2,963.50%	-2,961.95%
VERA	VERA THERAPEUTICS INC	$3.27B	-50.90%	-42.70%	-51.39%	-43.50%	0.30	12.21	N/A	N/A	N/A
BHVN	BIOHAVEN LTD	$1.15B	-389.90%	-153.40%	-263.08%	-206.40%	-24.84	2.86	N/A	N/A	N/A
PDSB	PDS BIOTECHNOLOGY CORP	$43.59M	-209.00%	-83.30%	-150.77%	-287.10%	2.67	2.09	N/A	N/A	N/A
IRON	DISC MEDICINE INC	$3.02B	-31.60%	-29.00%	-29.38%	-36.40%	0.10	23.45	N/A	N/A	N/A
AGIO	AGIOS PHARMACEUTICALS INC	$1.43B	-28.40%	-26.40%	-31.29%	-28.90%	0.08	13.82	87.20%	-895.90%	-915.68%

Biotech Stocks FAQ

What are the best biotech stocks to buy right now in Dec 2025?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best biotechnology stocks to buy right now are:

1. Alnylam Pharmaceuticals (NASDAQ:ALNY)

Alnylam Pharmaceuticals (NASDAQ:ALNY) is the #1 top biotech stock out of 617 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Alnylam Pharmaceuticals (NASDAQ:ALNY) is: Value: C, Growth: A, Momentum: C, Sentiment: A, Safety: D, Financials: B, and AI: B.

Alnylam Pharmaceuticals (NASDAQ:ALNY) has a Due Diligence Score of 45, which is 22 points higher than the biotech industry average of 23.

ALNY passed 16 out of 33 due diligence checks and has strong fundamentals. Alnylam Pharmaceuticals has seen its stock return 67.55% over the past year, overperforming other biotech stocks by 108 percentage points.

Alnylam Pharmaceuticals has an average 1 year price target of $491.28, an upside of 22.75% from Alnylam Pharmaceuticals's current stock price of $400.23.

Alnylam Pharmaceuticals stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 25 analysts covering Alnylam Pharmaceuticals, 48% have issued a Strong Buy rating, 36% have issued a Buy, 16% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Innoviva (NASDAQ:INVA)

Innoviva (NASDAQ:INVA) is the #2 top biotech stock out of 617 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Innoviva (NASDAQ:INVA) is: Value: A, Growth: C, Momentum: C, Sentiment: B, Safety: C, Financials: A, and AI: C.

Innoviva (NASDAQ:INVA) has a Due Diligence Score of 45, which is 22 points higher than the biotech industry average of 23.

INVA passed 14 out of 33 due diligence checks and has strong fundamentals. Innoviva has seen its stock return 11.49% over the past year, overperforming other biotech stocks by 52 percentage points.

Innoviva has an average 1 year price target of $32.25, an upside of 61.33% from Innoviva's current stock price of $19.99.

Innoviva stock has a consensus Buy recommendation according to Wall Street analysts. Of the 4 analysts covering Innoviva, 25% have issued a Strong Buy rating, 50% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 25% have issued a Strong Sell.

3. Beone Medicines (NASDAQ:ONC)

Beone Medicines (NASDAQ:ONC) is the #3 top biotech stock out of 617 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Beone Medicines (NASDAQ:ONC) is: Value: B, Growth: A, Momentum: B, Sentiment: A, Safety: C, Financials: C, and AI: B.

Beone Medicines (NASDAQ:ONC) has a Due Diligence Score of 53, which is 30 points higher than the biotech industry average of 23.

ONC passed 18 out of 33 due diligence checks and has strong fundamentals. Beone Medicines has seen its stock return 80.89% over the past year, overperforming other biotech stocks by 121 percentage points.

Beone Medicines has an average 1 year price target of $390.88, an upside of 23.68% from Beone Medicines's current stock price of $316.05.

Beone Medicines stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 8 analysts covering Beone Medicines, 75% have issued a Strong Buy rating, 25% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the biotech stocks with highest dividends?

Out of 4 biotech stocks that have issued dividends in the past year, the 3 biotech stocks with the highest dividend yields are:

1. Dominari Holdings (NASDAQ:DOMH)

Dominari Holdings (NASDAQ:DOMH) has an annual dividend yield of 11.79%, which is 9 percentage points higher than the biotech industry average of 2.89%.

Dominari Holdings's dividend payout ratio of 8.4% indicates that its high dividend yield is sustainable for the long-term.

2. Royalty Pharma (NASDAQ:RPRX)

Royalty Pharma (NASDAQ:RPRX) has an annual dividend yield of 2.28%, which is -1 percentage points lower than the biotech industry average of 2.89%. Royalty Pharma's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Royalty Pharma's dividend has shown consistent growth over the last 10 years.

Royalty Pharma's dividend payout ratio of 49.4% indicates that its dividend yield is sustainable for the long-term.

3. Bio Techne (NASDAQ:TECH)

Bio Techne (NASDAQ:TECH) has an annual dividend yield of 0.55%, which is -2 percentage points lower than the biotech industry average of 2.89%. Bio Techne's dividend payout is not stable, having dropped more than 10% one times in the last 10 years. Bio Techne's dividend has not shown consistent growth over the last 10 years.

Bio Techne's dividend payout ratio of 64% indicates that its dividend yield is sustainable for the long-term.

Why are biotech stocks up?

Biotech stocks were up 2.35% in the last day, and down -0.7% over the last week. Cypherpunk Technologies was the among the top gainers in the biotechnology industry, gaining 39.04% yesterday.

Cypherpunk Technologies shares are trading higher after the company announced the appointment of Electric Coin Company CEO Josh Swihart as its Strategic Advisor.

What are the most undervalued biotech stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued biotech stocks right now are:

1. Harmony Biosciences Holdings (NASDAQ:HRMY)

Harmony Biosciences Holdings (NASDAQ:HRMY) is the most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Harmony Biosciences Holdings has a valuation score of 57, which is 42 points higher than the biotech industry average of 15. It passed 4 out of 7 valuation due diligence checks.

Harmony Biosciences Holdings's stock has gained 11.57% in the past year. It has overperformed other stocks in the biotech industry by 52 percentage points.

2. Puma Biotechnology (NASDAQ:PBYI)

Puma Biotechnology (NASDAQ:PBYI) is the second most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Puma Biotechnology has a valuation score of 43, which is 28 points higher than the biotech industry average of 15. It passed 3 out of 7 valuation due diligence checks.

Puma Biotechnology's stock has gained 102.52% in the past year. It has overperformed other stocks in the biotech industry by 143 percentage points.

3. Innoviva (NASDAQ:INVA)

Innoviva (NASDAQ:INVA) is the third most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Innoviva has a valuation score of 43, which is 28 points higher than the biotech industry average of 15. It passed 3 out of 7 valuation due diligence checks.

Innoviva's stock has gained 11.49% in the past year. It has overperformed other stocks in the biotech industry by 52 percentage points.

Are biotech stocks a good buy now?

60.86% of biotech stocks rated by analysts are a strong buy right now. On average, analysts expect biotech stocks to rise by 50.11% over the next year.

3.51% of biotech stocks have a Zen Rating of A (Strong Buy), 6.39% of biotech stocks are rated B (Buy), 46.19% are rated C (Hold), 31.13% are rated D (Sell), and 12.78% are rated F (Strong Sell).

What is the average p/e ratio of the biotechnology industry?

The average P/E ratio of the biotechnology industry is 156.53x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.

Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2025)
Top biotech stocks in 2025 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.

Biotech Stocks FAQ

1. Alnylam Pharmaceuticals (NASDAQ:ALNY)

2. Innoviva (NASDAQ:INVA)

3. Beone Medicines (NASDAQ:ONC)

1. Dominari Holdings (NASDAQ:DOMH)

2. Royalty Pharma (NASDAQ:RPRX)

3. Bio Techne (NASDAQ:TECH)

1. Harmony Biosciences Holdings (NASDAQ:HRMY)

2. Puma Biotechnology (NASDAQ:PBYI)

3. Innoviva (NASDAQ:INVA)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcareBiotechnologyBest Biotech Stocks to Buy Now (2025)Top biotech stocks in 2025 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.

Biotech Stocks FAQ

1. Alnylam Pharmaceuticals (NASDAQ:ALNY)

2. Innoviva (NASDAQ:INVA)

3. Beone Medicines (NASDAQ:ONC)

1. Dominari Holdings (NASDAQ:DOMH)

2. Royalty Pharma (NASDAQ:RPRX)

3. Bio Techne (NASDAQ:TECH)

1. Harmony Biosciences Holdings (NASDAQ:HRMY)

2. Puma Biotechnology (NASDAQ:PBYI)

3. Innoviva (NASDAQ:INVA)

Company

Stock Tools

Stock Ideas

Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2025)
Top biotech stocks in 2025 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.